Kumar D, Kanchan R, Chaturvedi N
Discov Oncol. 2025; 16(1):23.
PMID: 39779613
PMC: 11711608.
DOI: 10.1007/s12672-025-01761-7.
Khaliq A, Rajamohan M, Saeed O, Mansouri K, Adil A, Zhang C
Nat Genet. 2024; 56(11):2455-2465.
PMID: 39294496
DOI: 10.1038/s41588-024-01914-4.
Forte G, Donghia R, Lepore Signorile M, Tatoli R, Bonfiglio C, Losito F
Int J Mol Sci. 2024; 25(17).
PMID: 39273459
PMC: 11394752.
DOI: 10.3390/ijms25179512.
Meena J, Wang J, Neill N, Keough D, Putluri N, Katsonis P
Cancer Discov. 2024; 14(9):1699-1716.
PMID: 39193992
PMC: 11372365.
DOI: 10.1158/2159-8290.CD-22-0649.
Casacuberta-Serra S, Gonzalez-Larreategui I, Capitan-Leo D, Soucek L
Signal Transduct Target Ther. 2024; 9(1):205.
PMID: 39164274
PMC: 11336233.
DOI: 10.1038/s41392-024-01907-z.
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer.
Fontana F, Giannitti G, Marchesi S, Limonta P
Int J Biol Sci. 2024; 20(8):3113-3125.
PMID: 38904014
PMC: 11186371.
DOI: 10.7150/ijbs.89942.
Multimodal Therapy Approaches for NUT Carcinoma by Dual Combination of Oncolytic Virus with Small Molecule Inhibitors.
Sotiriadis S, Beil J, Berchtold S, Smirnow I, Schenk A, Lauer U
Viruses. 2024; 16(5).
PMID: 38793657
PMC: 11125747.
DOI: 10.3390/v16050775.
PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies-New Therapeutic Possibilities.
Wiese W, Barczuk J, Racinska O, Siwecka N, Rozpedek-Kaminska W, Slupianek A
Cancers (Basel). 2023; 15(21).
PMID: 37958470
PMC: 10648005.
DOI: 10.3390/cancers15215297.
Strategies to target the cancer driver MYC in tumor cells.
Weber L, Hartl M
Front Oncol. 2023; 13:1142111.
PMID: 36969025
PMC: 10032378.
DOI: 10.3389/fonc.2023.1142111.
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity.
Bloedjes T, de Wilde G, Khan G, Ashby T, Shaughnessy J, Zhan F
Blood Adv. 2022; 7(9):1697-1712.
PMID: 36322819
PMC: 10182179.
DOI: 10.1182/bloodadvances.2022007383.
FOXO1 regulates pentose phosphate pathway-mediated induction of developmental erythropoiesis.
Monsalve A, Canals I, Oburoglu L
Front Cell Dev Biol. 2022; 10:1039636.
PMID: 36313554
PMC: 9596918.
DOI: 10.3389/fcell.2022.1039636.
Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: Their therapeutic potential and possible effects of salvianolic acids.
Han R, Huang H, Xia W, Liu J, Luo H, Tang J
Front Cardiovasc Med. 2022; 9:951597.
PMID: 36035917
PMC: 9403618.
DOI: 10.3389/fcvm.2022.951597.
TF-DUBTACs Stabilize Tumor Suppressor Transcription Factors.
Liu J, Yu X, Chen H, Umit Kaniskan H, Xie L, Chen X
J Am Chem Soc. 2022; 144(28):12934-12941.
PMID: 35786952
PMC: 10981454.
DOI: 10.1021/jacs.2c04824.
Time-resolved phosphoproteome and proteome analysis reveals kinase signaling on master transcription factors during myogenesis.
Xiao D, Caldow M, Kim H, Blazev R, Koopman R, Manandi D
iScience. 2022; 25(6):104489.
PMID: 35721465
PMC: 9198430.
DOI: 10.1016/j.isci.2022.104489.
Uncovering emergent phenotypes in endothelial cells by clustering of surrogates of cardiovascular risk factors.
Pinheiro-de-Sousa I, Fonseca-Alaniz M, Teixeira S, Rodrigues M, Krieger J
Sci Rep. 2022; 12(1):1372.
PMID: 35079076
PMC: 8789842.
DOI: 10.1038/s41598-022-05404-7.
Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas.
Parekh U, McDonald D, Dailamy A, Wu Y, Cordes T, Zhang K
iScience. 2021; 24(10):103149.
PMID: 34646987
PMC: 8496177.
DOI: 10.1016/j.isci.2021.103149.
p52Shc regulates the sustainability of ERK activation in a RAF-independent manner.
Yoshizawa R, Umeki N, Yamamoto A, Okada M, Murata M, Sako Y
Mol Biol Cell. 2021; 32(19):1838-1848.
PMID: 34260260
PMC: 8684710.
DOI: 10.1091/mbc.E21-01-0007.
Targeting therapy-resistant lung cancer stem cells via disruption of the AKT/TSPYL5/PTEN positive-feedback loop.
Kim I, Lee J, Kim S, Heo C, Kim R, Cho E
Commun Biol. 2021; 4(1):778.
PMID: 34163000
PMC: 8222406.
DOI: 10.1038/s42003-021-02303-x.
Linking Metabolic Reprogramming, Plasticity and Tumor Progression.
Shuvalov O, Daks A, Fedorova O, Petukhov A, Barlev N
Cancers (Basel). 2021; 13(4).
PMID: 33673109
PMC: 7917602.
DOI: 10.3390/cancers13040762.
Metabolic Codependencies in the Tumor Microenvironment.
Dey P, Kimmelman A, DePinho R
Cancer Discov. 2021; 11(5):1067-1081.
PMID: 33504580
PMC: 8102306.
DOI: 10.1158/2159-8290.CD-20-1211.